Kazan e-cigarette exhibition cancelled due to law change

Apr.18.2023
Kazan e-cigarette exhibition cancelled due to law change
The Kazan electronic cigarette exhibition, with over 300 brands, was cancelled due to a new law prohibiting sales to minors.

On April 17, the organizers of the Kazan electronic cigarette exhibition announced that it was cancelled due to the recently passed law banning the sale of electronic cigarettes to minors. The exhibition was previously scheduled to take place in May.


Unfortunately, following a political event, the government of the Republic of Tatarstan has banned an exhibition in Kazan. This announcement appeared today on the social media platform of Hookah & Vape Club Show, the world's largest shisha and e-cigarette exhibition, which was originally planned to be held at the Kazan Expo on May 6th and 7th.


At the electronic cigarette exhibition in Kazan, over 300 brands displayed hookah and electronic cigarette products in the two largest exhibition halls. The event was expected to receive around 10,000 visitors over the course of two days, with ticket prices ranging from 1500 to 3500 rubles per day.


The organizers of the electronic cigarette exhibition stated that the event has been held for 7 years.


Business Online reached out to the organizer of the exhibition, Asya Zakatova, who stated that she only received news of the event's cancellation from representatives of the Kazan Expo yesterday. At this time, it is unknown who made the decision to cancel the event. However, Zakatova is certain that media attention and negative publicity played a role in the cancellation of the exhibition.


Asya Zakatova stated that the event had already been held in St. Petersburg for seven years prior to this.


A representative from the State Duma proposes cancelling electronic cigarette exhibitions.


Earlier, Yaroslav Nilov, a deputy of the State Duma from the LDPR party, strongly advocated for the cancellation of an exhibition. He appealed to the Mayor of Kazan, Ilsur Metshin, requesting assistance in prohibiting the display of electronic cigarettes and their advertisement during the exhibition.


According to him, representatives of leaders from Tartarstan contacted him later and expressed their concern about the increasing scale of youth use of electronic cigarettes.


After the cancellation of the e-cigarette exhibition, he did not hide his satisfaction. "This is the right decision," he thanked and welcomed the cancellation announcement and hoped that other regions would follow the example of the leader of Tatarstan.


The World Expo in Kazan has declined to comment on the matter.


Topic: The Progress of Russia's Ban on E-Cigarette Flavors and Expert Interpretation (Click on the image below to jump)


Expert Analysis Series:


Expert analysis 1: The Russian ban on flavored e-cigarettes applies to all e-cigarette products, with specific additive standards yet to be disclosed.


Expert Analysis 2: Russia sets minimum retail price for e-cigarette products to reduce demand for nicotine products.


Expert analysis 3: Russian proposal suggests banning online sales and in-store displays of electronic cigarettes, to be effective starting June 1st.


Related reading:


Nicotine product manufacturers in Russia must apply for a license under a new bill that passed its first reading.


In one day, bill passes three readings: Timeline and background of Russian taste ban.


On September 1st, Russia's ban on flavored additives in electronic cigarettes will go into effect. The full proposal is included in the fourth article. On April 11th, the proposal to ban flavored electronic cigarettes will undergo its first discussion in Russia.


Russia proposes a maximum fine of 500,000 rubles for selling e-cigarettes to minors.


What is the progress of the ban on certain flavors in Russia's legislative process? Here's a breakdown of the legislative process in Russia.


References:


Tatarstan is the region with the highest smoking rates in Russia...": authorities have expelled vapers and hookah smokers from the "Kazan Expo" venue.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
GAO Audit Finds Nearly 132,000 FDA Tobacco Applications Waiting an Average 1,266 Days as Nicotine Pouch Pilot Practices Move Into Vape PMTA Reviews
A U.S. Government Accountability Office audit found that 131,915 tobacco product applications submitted to the FDA since 2018 remained without a final review as of December 31, 2025, with pending applications waiting an average of 1,266 days. GAO also found FDA lacks the data needed to systematically determine whether scientific reviews meet applicable timelines. HHS agreed to upgrade the agency's tracking systems. At the same time, FDA has begun applying lessons from its nicotine pouch PMTA pilot to e-cigarette reviews, while changes to enforcement policy and electronic submissions are making the specific stage of a PMTA increasingly relevant to market access.
FDA
Oct.03
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
Juul Displays FDA-Authorized JUUL2, Highlights Age Verification at NACS Show 2026
At the 2026 NACS Show in Las Vegas, Juul Labs displayed its JUUL2 e-cigarette system alongside existing products, age-verification messaging and mobile coupons, 2Firsts observed. The JUUL2 device and Virginia Tobacco and Polar Menthol pods received FDA marketing authorization in August 2026. Booth materials highlighted longer battery life, greater e-liquid capacity and connected-device features. A TruAge sign and a mobile coupon presentation also featured at the booth, with weekly offers available to age-verified adult nicotine consumers at participating retailers.
EXPO
Oct.09
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
JUUL Purchasers Ask Ninth Circuit to Preserve Antitrust Classes in Case Over Altria’s $12.8 Billion Investment
Private antitrust litigation stemming from Altria's 2018 $12.8 billion investment for a 35% economic interest in JUUL is advancing before the U.S. Court of Appeals for the Ninth Circuit. Direct purchasers, indirect purchasers and indirect resellers of JUUL products filed answering briefs this week seeking to preserve class certifications granted by a California federal court in February. Altria and JUUL argue that individual consumers and large distributors differ too much in purchasing terms to remain in a single direct-purchaser class, while a separate dispute concerns whether California antitrust law can apply to indirect purchasers across 27 jurisdictions. A September trial has been put on hold during the appeal.
Sep.23
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
NAS 2026 | FDA CTP Director Says PMTA Pathway Is “Predicated on Tobacco Harm Reduction”
At the 2026 New Approaches Summit in New York, FDA Center for Tobacco Products Director Bret Koplow said the PMTA pathway is “predicated on tobacco harm reduction.” He outlined four CTP priorities: youth prevention, helping adults quit or switch to lower-risk products, improving relative-risk communication, and reducing unauthorized products. Koplow also addressed flavored e-cigarettes, public risk perceptions, industry credibility and efforts to make PMTA reviews more efficient and predictable.
Sep.26
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
PMI Expands U.S. ZYN Portfolio With New 1.5 mg and 8 mg Strengths, Moves Toward a Unified 20-Pouch-Per-Can Format
Philip Morris International is expanding its U.S. ZYN nicotine pouch portfolio with new 1.5 mg and 8 mg strengths and plans to move its core 3 mg and 6 mg dry-pouch products from 15 to 20 pouches per can in the fourth quarter of 2026. ZYN ULTRA is also commercially available, with FDA authorization covering 10 products at 9 mg and one 11 mg Smooth product. PMI U.S. lists the new 1.5 mg and 8 mg strengths as commercially available, but as of September 10 they do not appear on the FDA’s public authorization list. Public materials do not identify which PMTA submissions cover the two new strengths or their current review status.
Sep.11